Options in Renal Replacement Therapy

  • Alex M. Davison


Since the introduction over forty years ago of regular dialysis therapy for the management of end stage renal failure there have been dramatic changes in the way this treatment is provided. In pioneering days only a few highly selected patients were considered for treatment and only one treatment option was available (9). Generally, patients were treated twice weekly by haemodialysis for 14 hours with equipment which was, by present day standards, rather inefficient with little or no monitoring. Research and development has resulted in significant advances in dialyser design, membrane performance, and monitoring devices with the consequence that patients are now treated with expensive sophisticated equipment utilising computer assisted controls. Unlike the previous ‘fixed’ regimen patients now have the possibility of treatment ’tailored’ to their individual requirement by using measurements of dialysis adequacy to determine the length of each dialysis session and currently patients’ haemodialysis sessions vary from 2.5 to 6 hours twice or, more commonly, thrice weekly


Peritoneal Dialysis Renal Replacement Therapy Vascular Access Continuous Ambulatory Peritoneal Dialysis Nephrol Dial Transplant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barrett N, Spencer S, McIvor J, Brown E: Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant 3: 423, 1988PubMedGoogle Scholar
  2. 2.
    Brekke I, Drybekk D, Jakobsen, A et al.: Combined kidney and pancreas transplantation for diabetic nephropathy. Transplant Proc 18: 63, 1986Google Scholar
  3. 3.
    Challah S, Wing AJ, Bauer R et al.: Negative selection of patients for dialysis and transplantation in the United Kingdom. Br Med J 228: 1119, 1984Google Scholar
  4. 4.
    Cole EH: Renal transplantation in the elderly: the Toronto experience, in Nephrology and Urology in the Aged Patient, edited by Oreopoulos DG, Michelis MF, Herschorn S, Kluwer Academic Publishers, Dordrecht, 1993, p 349Google Scholar
  5. 5.
    Coward RA, Mallick NP, Delamore IW: Should patients with renal failure associated with myeloma be dialysed? Br Med J 287: 1575, 1983Google Scholar
  6. 6.
    Davison AM, Roberts TG, Mascie-Taylor BH, Lewins AM: Haemofiltration for profound dialysis induced hypotension: removal of salt and water without blood pressure change. Br Med J 285: 87, 1982Google Scholar
  7. 7.
    Fassbinder W, Brunner FP, Brynger H et al.: Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 6(Suppl 1): 5, 1991Google Scholar
  8. 8.
    Gejyo F, Yamada T, Odani S et al.: A new form of amyloid protein associated with chronic haemodialysis was identified as /?2-microglobulin. Biochemical Biophysical Research Communications 129: 701, 1985CrossRefGoogle Scholar
  9. 9.
    Hegstrom RM, Murray JS, Pendras JP et al.: Hemodialysis in the treatment of chronic uraemia. Trans Am Soc Artif Organs 7: 136, 1966Google Scholar
  10. 10.
    Innes A, Rowe PA, Burden RP, Morgan AG: Early deaths on renal replacement therapy: the need for early nephrology referral. Nephrol Dial Transplant 7: 467, 1992PubMedGoogle Scholar
  11. 11.
    Maiorca R et al.: A six year comparison of patient and technique survivals in CAPD and HD. Kidney Int 34: 518, 1988PubMedCrossRefGoogle Scholar
  12. 12.
    Morris GE, Jamieson NV, Small J, Evans DB, Calne R: Cadaveric renal transplantation in elderly patients: is it worthwhile? Nephrol Dial Transplant 6: 887, 1991PubMedGoogle Scholar
  13. 13.
    Ninon, C, Oules R, Canaud B et al.: Maintenance dialysis in the elderly: a review of 15 years’ experience. Proc EDTA-ERA 21: 490, 1984Google Scholar
  14. 14.
    Ost L, Groth C-G, Lindholm B et al.: Cadaveric renal transplantation in patients of 60 years and above. Transplant 30: 339, 1980CrossRefGoogle Scholar
  15. 15.
    Poikolainen K, Eskola J: Health services resources and their relation to mortality from causes amenable to health care intervention: a cross-national study. Int J Epidemiol 17: 86, 1988PubMedCrossRefGoogle Scholar
  16. 16.
    Popovich RP, Moncrief JW, Dechard JF et al.: The definition of a novel portable/wearable equilibrium dialysis technique. Trans Am Soc Artif Intern Organs 5: 64, 1976Google Scholar
  17. 17.
    Rotellar E, Lubelza RA, Rotellar C et al.: Must patients over 65 be haemodialysed. Nephron 41: 152, 1985PubMedGoogle Scholar
  18. 18.
    Rowe JW, Andres R, Tobin JD et al.: The effect of age on creatinine clearance in man: a cross sectional and longitudinal survey. J Gerentol 31: 155, 1976Google Scholar
  19. 19.
    Scharer K et al.: Pubertal development in children with renal failure. Pediatric and Adolescent Endocrinology 20: 151, 1989Google Scholar
  20. 20.
    Shaldon S, Baillod RA, Compty C et al.: 18 months experience with a nurse-patient operated chronic dialysis unit. Proc Eur Dial Transplant Assoc 1: 233, 1964Google Scholar
  21. 21.
    Spitzer WO: State of science 1986: quality of life and functional status as target variables for research. J Chron Dis 40: 465, 1987PubMedCrossRefGoogle Scholar
  22. 22.
    Tapsan JS, Rodger RSC, Mansy H et al.: Renal replacement therapy in patients aged over 60 years. Postgrad Med J 63: 1071, 1987CrossRefGoogle Scholar
  23. 23.
    Woods HF: Perspectives on dialysis in the third world: a problem of economics. Contrib Nephrol 102: 237, 1993PubMedGoogle Scholar
  24. 24.
    Valek A, Wing AJ: Development of dialysis and transplant activity in the world in the seventies of the 20th century. Z Exp Chir Transplant Künstliche Organe 17: 69, 1984PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Alex M. Davison
    • 1
  1. 1.Department of Renal MedicineSt. James’s University HospitalLeedsEngland

Personalised recommendations